These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Imatinib mesilate inhibits neointimal hyperplasia via growth inhibition of vascular smooth muscle cells in a rat model of balloon injury. Makiyama Y; Toba K; Kato K; Hirono S; Ozawa T; Saigawa T; Minagawa S; Isoda M; Asami F; Ikarashi N; Oda M; Moriyama M; Higashimura M; Kitajima T; Otaki K; Aizawa Y Tohoku J Exp Med; 2008 Aug; 215(4):299-306. PubMed ID: 18679003 [TBL] [Abstract][Full Text] [Related]
4. Inhibition of platelet-derived growth factor receptor tyrosine kinase inhibits vascular smooth muscle cell migration and proliferation. Myllärniemi M; Calderon L; Lemström K; Buchdunger E; Häyry P FASEB J; 1997 Nov; 11(13):1119-26. PubMed ID: 9367346 [TBL] [Abstract][Full Text] [Related]
5. Combined vascular endothelial growth factor and platelet-derived growth factor inhibition in rat cardiac allografts: beneficial effects on inflammation and smooth muscle cell proliferation. Nykänen AI; Krebs R; Tikkanen JM; Raisky O; Sihvola R; Wood J; Koskinen PK; Lemström KB Transplantation; 2005 Jan; 79(2):182-9. PubMed ID: 15665766 [TBL] [Abstract][Full Text] [Related]
6. Counter-regulatory function of protein tyrosine phosphatase 1B in platelet-derived growth factor- or fibroblast growth factor-induced motility and proliferation of cultured smooth muscle cells and in neointima formation. Chang Y; Ceacareanu B; Zhuang D; Zhang C; Pu Q; Ceacareanu AC; Hassid A Arterioscler Thromb Vasc Biol; 2006 Mar; 26(3):501-7. PubMed ID: 16373608 [TBL] [Abstract][Full Text] [Related]
7. Role of E2F and ERK1/2 in STI571-mediated smooth muscle cell growth arrest and cyclin A transcriptional repression. Sanz-González SM; Castro C; Pérez P; Andrés V Biochem Biophys Res Commun; 2004 May; 317(4):972-9. PubMed ID: 15094364 [TBL] [Abstract][Full Text] [Related]
8. Oral imatinib mesylate (STI571/gleevec) improves the efficacy of local intravascular vascular endothelial growth factor-C gene transfer in reducing neointimal growth in hypercholesterolemic rabbits. Leppänen O; Rutanen J; Hiltunen MO; Rissanen TT; Turunen MP; Sjöblom T; Brüggen J; Bäckström G; Carlsson M; Buchdunger E; Bergqvist D; Alitalo K; Heldin CH; Ostman A; Ylä-Herttuala S Circulation; 2004 Mar; 109(9):1140-6. PubMed ID: 14769706 [TBL] [Abstract][Full Text] [Related]
9. Differential effects of imatinib on PDGF-induced proliferation and PDGF receptor signaling in human arterial and venous smooth muscle cells. Li L; Blumenthal DK; Masaki T; Terry CM; Cheung AK J Cell Biochem; 2006 Dec; 99(6):1553-63. PubMed ID: 16817200 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of cell growth: effects of the tyrosine kinase inhibitor CGP 53716. Major TC; Keiser JA J Pharmacol Exp Ther; 1997 Oct; 283(1):402-10. PubMed ID: 9336349 [TBL] [Abstract][Full Text] [Related]
11. Adenovirus-mediated transfer of the herpes simplex virus thymidine kinase gene inhibits vascular smooth muscle cell proliferation and neointima formation following balloon angioplasty of the rat carotid artery. Chang MW; Ohno T; Gordon D; Lu MM; Nabel GJ; Nabel EG; Leiden JM Mol Med; 1995 Jan; 1(2):172-81. PubMed ID: 8529096 [TBL] [Abstract][Full Text] [Related]
12. Curcumin inhibits platelet-derived growth factor-stimulated vascular smooth muscle cell function and injury-induced neointima formation. Yang X; Thomas DP; Zhang X; Culver BW; Alexander BM; Murdoch WJ; Rao MN; Tulis DA; Ren J; Sreejayan N Arterioscler Thromb Vasc Biol; 2006 Jan; 26(1):85-90. PubMed ID: 16239599 [TBL] [Abstract][Full Text] [Related]
13. Platelet-derived growth factor receptor antagonist STI571 (imatinib mesylate) inhibits human vascular smooth muscle proliferation and migration in vitro but not in vivo. Hacker TA; Griffin MO; Guttormsen B; Stoker S; Wolff MR J Invasive Cardiol; 2007 Jun; 19(6):269-74. PubMed ID: 17541129 [TBL] [Abstract][Full Text] [Related]
14. 8-chloro-cAMP inhibits smooth muscle cell proliferation in vitro and neointima formation induced by balloon injury in vivo. Indolfi C; Di Lorenzo E; Rapacciuolo A; Stingone AM; Stabile E; Leccia A; Torella D; Caputo R; Ciardiello F; Tortora G; Chiariello M J Am Coll Cardiol; 2000 Jul; 36(1):288-93. PubMed ID: 10898448 [TBL] [Abstract][Full Text] [Related]
15. Potent inhibition of platelet-derived growth factor-induced responses in vascular smooth muscle cells by BMS-354825 (dasatinib). Chen Z; Lee FY; Bhalla KN; Wu J Mol Pharmacol; 2006 May; 69(5):1527-33. PubMed ID: 16436588 [TBL] [Abstract][Full Text] [Related]
16. Local delivery of platelet-derived growth factor receptor-specific tyrphostin inhibits neointimal formation in rats. Fishbein I; Waltenberger J; Banai S; Rabinovich L; Chorny M; Levitzki A; Gazit A; Huber R; Mayr U; Gertz SD; Golomb G Arterioscler Thromb Vasc Biol; 2000 Mar; 20(3):667-76. PubMed ID: 10712389 [TBL] [Abstract][Full Text] [Related]
17. Lercanidipine inhibits vascular smooth muscle cell proliferation and neointimal formation via reducing intracellular reactive oxygen species and inactivating Ras-ERK1/2 signaling. Wu JR; Liou SF; Lin SW; Chai CY; Dai ZK; Liang JC; Chen IJ; Yeh JL Pharmacol Res; 2009 Jan; 59(1):48-56. PubMed ID: 18973813 [TBL] [Abstract][Full Text] [Related]
18. Inhibition of PDGF receptor binding and PDGF-stimulated biological activity in vitro and of intimal lesion formation in vivo by 2-bromomethyl-5-chlorobenzene sulfonylphthalimide. Mullins DE; Hamud F; Reim R; Davis HR Arterioscler Thromb; 1994 Jul; 14(7):1047-55. PubMed ID: 8018659 [TBL] [Abstract][Full Text] [Related]
20. Effects of blocking platelet-derived growth factor-receptor signaling in a mouse model of experimental prostate cancer bone metastases. Uehara H; Kim SJ; Karashima T; Shepherd DL; Fan D; Tsan R; Killion JJ; Logothetis C; Mathew P; Fidler IJ J Natl Cancer Inst; 2003 Mar; 95(6):458-70. PubMed ID: 12644539 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]